Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    "Langerhans cell histiocytosis"
Show Display Options
RSS Create an RSS feed from your search for:
"Langerhans cell histiocytosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Phase II Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Intervention: Drug: Clofarabine
2 Recruiting LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Interventions: Drug: Prednisone;   Drug: Vinblastine;   Drug: mercaptopurine;   Drug: INDOMETHACIN;   Drug: Methotrexate;   Drug: Cytosine Arabinoside;   Drug: 2-chlorodeoxyadenosine;   Procedure: hematopoietic stem cell transplantation (RIC-HSCT);   Biological: Intravenous immunoglobulin
3 Completed Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis
Condition: Childhood Langerhans Cell Histiocytosis
Interventions: Drug: leucovorin calcium;   Drug: methotrexate;   Drug: prednisolone;   Drug: vinblastine sulfate
4 Completed Evaluation of Outcome of Adult Pulmonary Langerhans Cell Histiocytosis Based on Lung HRCT and Lung Function
Condition: Pulmonary Langerhans Cell Histiocytosis
Intervention:
5 Recruiting Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Intervention: Drug: methotrexate
6 Recruiting Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
Condition: Langerhans Cell Histiocytosis
Interventions: Drug: Cytarabine;   Drug: Vinblastine/prednisone
7 Recruiting Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Intervention:
8 Unknown  A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Intervention: Drug: GSK2110183
9 Active, not recruiting Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis of Lung
Intervention: Drug: Cladribine
10 Completed Prospective Evaluation of Adult Pulmonary Langerhans Cell Histiocytosis
Condition: Adult Pulmonary Langerhans Cell Histiocytosis
Intervention: Behavioral: Tabacco discontinuation
11 Withdrawn Clofarabine for Langerhans in Pedi
Condition: Langerhans Cell Histiocytosis
Intervention: Drug: Clofarabine
12 Completed
Has Results
Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH
Condition: Langerhans Cell Histiocytosis
Interventions: Drug: Methotrexate;   Drug: 6-Thioguanine;   Drug: Leucovorin Calcium
13 Terminated
Has Results
Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis
Condition: Histiocytosis, Langerhans-cell
Interventions: Biological: alemtuzumab;   Drug: fludarabine phosphate;   Drug: melphalan;   Procedure: stem cell transplantation
14 Completed Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL
Condition: Histiocytosis, Langerhans-Cell
Intervention: Drug: Etanercept
15 Completed H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis
Condition: Leukemia
Interventions: Drug: Prednisone, Vinblastin, 6-mercaptopuroine;   Drug: Leucovorin, Methotrexate, Vinblastine, Prednisone
16 Recruiting A Study of Lenalidomide for Adult Histiocyte Disorders
Conditions: Langerhans Cell Histiocytosis (LCH);   Histiocytoses Erdheim-chester Disease;   Histiocytic Sarcoma (HS)
Intervention: Drug: Lenalidomide
17 Recruiting Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement
Conditions: Erdheim-Chester Disease;   Langerhans Cell Histiocytosis;   Histiocytic Disorders
Interventions: Radiation: F-choline PET Scan;   Device: FDG-PET;   Procedure: biopsy
18 Unknown  Cardiovascular Risk Factors and LCH in Adults
Condition: Histiocytosis, Langerhans-Cell
Intervention:
19 Terminated Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer
Conditions: Adult Langerhans Cell Histiocytosis;   Childhood Langerhans Cell Histiocytosis;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Intervention: Procedure: Peripheral Blood Stem Cell Transplantation
20 Unknown  Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
Conditions: Childhood Langerhans Cell Histiocytosis;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Intervention: Procedure: umbilical cord blood transplantation

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.